Travere Therapeutics to Present Key Data on FILSPARI™ (Sparsentan) in IgA Nephropathy and FSGS at ASN Kidney Week 2024
Travere Therapeutics, Inc., announced that the Company will present 11 abstracts, including one late-breaking abstract at the upcoming American Society of Nephrology (ASN) Kidney Week 2024 in San Diego, CA, October 23-27,… read more.